Dominguez Casas, L. C.Calvo-Rio, V.Beltran, E.S-Burson, J.Mesquida, M.Adan, A.Hernandez, M.L-Longo, F.H-Grafella, M.Valls, E.M-Costa, L.Sellas, A.G-Serrano, J.Callejas, J.Ortego, N.Herreras, J.Follonosa, A.Maiz, O.Blanco, A.Torre, I.F-Espartero, C.Jovani, V.Peitado, D.Diaz-Valle, D.Pato, E.F-Cid, C.Aurrecoechea, E.Garcia, M.Caracuel, M.Atanes, A.Francisco, F.Insua, S.Gonzalez-Suarez, S.S-Andrade, A.Linares, L.Romero, F.Garcia, A.Almodovar, R.Minguez, E.Carrasco, C.Raya, E.Alcalde, M.F-Carballido, C.Pages, F.Gonzalez-Vela, M.Fernandez-Diaz, C.Vegas-Revenga, N.Demetrio-Pablo, R.Gonzalez-Gay, M.Blanco, R.2025-01-072025-01-072017-06-010003-4967https://hdl.handle.net/10668/25909enLONG-TERM AND OPTIMIZATION OF INFLIXIMAB IN REFRACTORY UVEITIS ASSOCIATED TO BEHCET DISEASE. MULTICENTRE STUDY OF 100 PATIENTSconference outputopen access10.1136/annrheumdis-2017-eular.62261468-2060https://ard.bmj.com/content/annrheumdis/76/Suppl_2/718.3.full.pdf413181402171